InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,522.30
(
1.58%
)
US TECH 100
18,928.00
(
3.42%
)
Dow Jones
40,842.79
(
0.24%
)
Brent Oil
81.51
(
3.75%
)
Bitcoin
65,005.51
(
-1.76%
)

Replies to post #99 on Nektar Therapeutics (NKTR)

Replies to #99 on Nektar Therapeutics (NKTR)
icon url

easymoney123

03/29/12 12:39 AM

#100 RE: surf1944 #99

Surf, are you still holding NKTR?
icon url

surf1944

04/02/12 9:22 AM

#102 RE: surf1944 #99

8:55AM On The Wires (WIRES) :Nektar Therapeutics (NKTR) announced that the first subjects were dosed last week in a Phase 1 clinical study to evaluate the pharmacokinetics and safety of NKTR-192, the co's short-acting mu-opioid analgesic candidate.